2024-09-012025-08-312025-08-31false14323037THERAPY BEAU LTD2025-12-2986900falseiso4217:GBPxbrli:pure143230372024-08-31143230372025-08-31143230372024-09-012025-08-31143230372023-08-31143230372024-08-31143230372023-09-012024-08-3114323037bus:SmallEntities2024-09-012025-08-3114323037bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3114323037bus:FullAccounts2024-09-012025-08-3114323037bus:PrivateLimitedCompanyLtd2024-09-012025-08-3114323037core:WithinOneYear2025-08-3114323037core:AfterOneYear2025-08-3114323037core:WithinOneYear2024-08-3114323037core:AfterOneYear2024-08-3114323037core:ShareCapital2025-08-3114323037core:SharePremium2025-08-3114323037core:RevaluationReserve2025-08-3114323037core:OtherReservesSubtotal2025-08-3114323037core:RetainedEarningsAccumulatedLosses2025-08-3114323037core:ShareCapital2024-08-3114323037core:SharePremium2024-08-3114323037core:RevaluationReserve2024-08-3114323037core:OtherReservesSubtotal2024-08-3114323037core:RetainedEarningsAccumulatedLosses2024-08-3114323037core:LandBuildings2025-08-3114323037core:PlantMachinery2025-08-3114323037core:Vehicles2025-08-3114323037core:FurnitureFittings2025-08-3114323037core:OfficeEquipment2025-08-3114323037core:NetGoodwill2025-08-3114323037core:IntangibleAssetsOtherThanGoodwill2025-08-3114323037core:ListedExchangeTraded2025-08-3114323037core:UnlistedNon-exchangeTraded2025-08-3114323037core:LandBuildings2024-08-3114323037core:PlantMachinery2024-08-3114323037core:Vehicles2024-08-3114323037core:FurnitureFittings2024-08-3114323037core:OfficeEquipment2024-08-3114323037core:NetGoodwill2024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2024-08-3114323037core:ListedExchangeTraded2024-08-3114323037core:UnlistedNon-exchangeTraded2024-08-3114323037core:LandBuildings2024-09-012025-08-3114323037core:PlantMachinery2024-09-012025-08-3114323037core:Vehicles2024-09-012025-08-3114323037core:FurnitureFittings2024-09-012025-08-3114323037core:OfficeEquipment2024-09-012025-08-3114323037core:NetGoodwill2024-09-012025-08-3114323037core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3114323037core:ListedExchangeTraded2024-09-012025-08-3114323037core:UnlistedNon-exchangeTraded2024-09-012025-08-3114323037core:MoreThanFiveYears2024-09-012025-08-3114323037core:Non-currentFinancialInstruments2025-08-3114323037core:Non-currentFinancialInstruments2024-08-3114323037dpl:CostSales2024-09-012025-08-3114323037dpl:DistributionCosts2024-09-012025-08-3114323037core:LandBuildings2024-09-012025-08-3114323037core:PlantMachinery2024-09-012025-08-3114323037core:Vehicles2024-09-012025-08-3114323037core:FurnitureFittings2024-09-012025-08-3114323037core:OfficeEquipment2024-09-012025-08-3114323037dpl:AdministrativeExpenses2024-09-012025-08-3114323037core:NetGoodwill2024-09-012025-08-3114323037core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3114323037dpl:GroupUndertakings2024-09-012025-08-3114323037dpl:ParticipatingInterests2024-09-012025-08-3114323037dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3114323037core:ListedExchangeTraded2024-09-012025-08-3114323037dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3114323037core:UnlistedNon-exchangeTraded2024-09-012025-08-3114323037dpl:CostSales2023-09-012024-08-3114323037dpl:DistributionCosts2023-09-012024-08-3114323037core:LandBuildings2023-09-012024-08-3114323037core:PlantMachinery2023-09-012024-08-3114323037core:Vehicles2023-09-012024-08-3114323037core:FurnitureFittings2023-09-012024-08-3114323037core:OfficeEquipment2023-09-012024-08-3114323037dpl:AdministrativeExpenses2023-09-012024-08-3114323037core:NetGoodwill2023-09-012024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3114323037dpl:GroupUndertakings2023-09-012024-08-3114323037dpl:ParticipatingInterests2023-09-012024-08-3114323037dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3114323037core:ListedExchangeTraded2023-09-012024-08-3114323037dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3114323037core:UnlistedNon-exchangeTraded2023-09-012024-08-3114323037core:NetGoodwill2025-08-3114323037core:IntangibleAssetsOtherThanGoodwill2025-08-3114323037core:LandBuildings2025-08-3114323037core:PlantMachinery2025-08-3114323037core:Vehicles2025-08-3114323037core:FurnitureFittings2025-08-3114323037core:OfficeEquipment2025-08-3114323037core:AfterOneYear2025-08-3114323037core:WithinOneYear2025-08-3114323037core:ListedExchangeTraded2025-08-3114323037core:UnlistedNon-exchangeTraded2025-08-3114323037core:ShareCapital2025-08-3114323037core:SharePremium2025-08-3114323037core:RevaluationReserve2025-08-3114323037core:OtherReservesSubtotal2025-08-3114323037core:RetainedEarningsAccumulatedLosses2025-08-3114323037core:NetGoodwill2024-08-3114323037core:IntangibleAssetsOtherThanGoodwill2024-08-3114323037core:LandBuildings2024-08-3114323037core:PlantMachinery2024-08-3114323037core:Vehicles2024-08-3114323037core:FurnitureFittings2024-08-3114323037core:OfficeEquipment2024-08-3114323037core:AfterOneYear2024-08-3114323037core:WithinOneYear2024-08-3114323037core:ListedExchangeTraded2024-08-3114323037core:UnlistedNon-exchangeTraded2024-08-3114323037core:ShareCapital2024-08-3114323037core:SharePremium2024-08-3114323037core:RevaluationReserve2024-08-3114323037core:OtherReservesSubtotal2024-08-3114323037core:RetainedEarningsAccumulatedLosses2024-08-3114323037core:NetGoodwill2023-08-3114323037core:IntangibleAssetsOtherThanGoodwill2023-08-3114323037core:LandBuildings2023-08-3114323037core:PlantMachinery2023-08-3114323037core:Vehicles2023-08-3114323037core:FurnitureFittings2023-08-3114323037core:OfficeEquipment2023-08-3114323037core:AfterOneYear2023-08-3114323037core:WithinOneYear2023-08-3114323037core:ListedExchangeTraded2023-08-3114323037core:UnlistedNon-exchangeTraded2023-08-3114323037core:ShareCapital2023-08-3114323037core:SharePremium2023-08-3114323037core:RevaluationReserve2023-08-3114323037core:OtherReservesSubtotal2023-08-3114323037core:RetainedEarningsAccumulatedLosses2023-08-3114323037core:AfterOneYear2024-09-012025-08-3114323037core:WithinOneYear2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3114323037core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3114323037core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3114323037core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3114323037core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3114323037core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3114323037bus:Director12024-09-012025-08-31

THERAPY BEAU LTD

Registered Number
14323037
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

THERAPY BEAU LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director

ROBERTS, Beau-Jessica Ruth

Registered Address

2 Colchester Road
St. Osyth
Clacton-On-Sea
CO16 8HA

Registered Number

14323037 (England and Wales)
THERAPY BEAU LTD
Balance Sheet as at
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,4035,644
4,4035,644
Current assets
Debtors-128
Cash at bank and on hand15,63724,225
15,63724,353
Creditors amounts falling due within one year4(9,617)(9,737)
Net current assets (liabilities)6,02014,616
Total assets less current liabilities10,42320,260
Net assets10,42320,260
Capital and reserves
Profit and loss account10,42320,260
Shareholders' funds10,42320,260
The financial statements were approved and authorised for issue by the Director on 29 December 2025, and are signed on its behalf by:
ROBERTS, Beau-Jessica Ruth
Director
Registered Company No. 14323037
THERAPY BEAU LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
2.Average number of employees

20252024
Average number of employees during the year10
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 September 243,9005,3179,217
Additions-227227
At 31 August 253,9005,5449,444
Depreciation and impairment
At 01 September 241,2942,2793,573
Charge for year6528161,468
At 31 August 251,9463,0955,041
Net book value
At 31 August 251,9542,4494,403
At 31 August 242,6063,0385,644
4.Creditors: amounts due within one year

2025

2024

££
Taxation and social security9,6179,737
Total9,6179,737
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.